Apomorphine for treating or improving post-traumatic stress disorder

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating mental illness, comprising apomorphine or a pharmaceutically acceptable salt thereof as an active ingredient, a health functional food composition for preventing or improving mental illness, a method for preventing or treating mental illness, a method for preparing an animal model of induced mental illness, and an animal model prepared according to the method. The composition comprising apomorphine as an active ingredient of the present invention can induce changes in neuroplasticity by specifically enhancing the action of Drd4 dopamine receptors that mediate the formation of fear memories, and thus has the advantage of effectively preventing, treating, or alleviating post-traumatic stress disorder.

Dependencies are inferred from the claim text.